Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Triple Reuptake Inhibitors - Race to Market

Posted by jrbecker on September 27, 2005, at 8:20:32

DOV Pharmaceutical, Inc. Announces Phase II Efficacy Results for One of its Novel Antidepressants, DOV 216,303


http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-27-2005/0004132415&EDATE=


Neurosearch to start phase 3 tests of depression treatment NS2359 next year

http://www.forbes.com/markets/feeds/afx/2005/09/23/afx2240564.html

Triple reuptake inhibitors will inherit depression market

http://www.drugresearcher.com/news/news-ng.asp?id=61172-antidepressant-glaxosmithkline-merck

For more compounds in development, see...

http://neurotransmitter.net/newdrugs.html

Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in
This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker thread:560146
URL: http://www.dr-bob.org/babble/20050927/msgs/560146.html